#Saudi Arabia #Riyadh #healthcare #Bristol Myers Squibb #Osama Braiwish

Bristol Myers Squibb Appoints Osama Braiwish as General Manager for Saudi Arabia and Gulf Countries

Bristol Myers Squibb (BMS), a foremost player in the global biopharmaceutical industry, has unveiled its latest leadership appointment. Osama Braiwish has been named the General Manager for Saudi Arabia and the Gulf Countries, a strategic move aimed at bolstering the company's presence in this critical region. BMS operates not only in Saudi Arabia but also oversees operations in the United Arab Emirates, Kuwait, Qatar, Oman, Bahrain, and Jordan, making this role pivotal for regional healthcare advancements.

In an official statement, Braiwish expressed his enthusiasm about joining BMS, saying, "I'm incredibly proud to join Bristol Myers Squibb. The company is deeply devoted to driving innovation and significantly transforming patients' lives through science." With the healthcare landscape in the Gulf region continuously evolving, BMS is poised to enhance access to groundbreaking therapies, addressing high unmet medical needs in areas such as hematology, oncology, and cardiovascular diseases.

Leadership and Vision

Braiwish's extensive experience in the pharmaceutical and diagnostics sectors, accumulated over more than 25 years, gives him a profound understanding of both the market and its challenges. Prior to joining BMS, he held various significant leadership positions that focused on enhancing patient access to advanced therapies. His track record of operational excellence and ability to foster high-performing teams across diverse regions aligns perfectly with BMS's vision for sustainable health outcomes.

Michelle Calope, Senior Vice President of the Intercon Region for BMS, commented on the appointment, stating, "We are very pleased to have Osama lead the team in Saudi Arabia and the Gulf Markets. This region represents a crucial segment of our international strategy. Osama is well positioned to drive growth, encourage innovation, and cultivate an inclusive, high-performing team. We look forward to his leadership in boosting access to cutting-edge therapies and strengthening partnerships to support sustainable healthcare outcomes in the region."

Emphasis on Collaboration

One of Braiwish’s primary goals as General Manager will be to forge impactful collaborations within the healthcare ecosystem, ensuring that patients benefit from the latest therapeutic advancements. He aims to position BMS as a frontrunner in the biopharmaceutical arena by facilitating better access to treatments that can change lives.

Braiwish's vision is aligned with BMS’s mission to discover, develop, and deliver innovative medicines that address serious diseases, particularly in oncology, hematology, immunology, and cardiovascular health. This commitment is reflected in BMS’s ongoing efforts and initiatives to tackle pressing medical challenges faced by patients in the Gulf region.

About Bristol Myers Squibb

Bristol Myers Squibb continues to lead in biopharma, focusing on pioneering solutions for patients grappling with serious health conditions. With its expansive portfolio of therapies, the company remains dedicated to transforming patient lives through scientific innovation. For more details on BMS and its initiatives, visit www.bms.com.

As BMS charts its future under Braiwish's stewardship in Saudi Arabia and the Gulf countries, the region could see transformative changes in how healthcare is delivered and accessed, a promising prospect for many in these communities.